Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

Solan AN, Cesaretti JA, Stone NN, Stock RG.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1468-74. doi: 10.1016/j.ijrobp.2008.06.1946. Epub 2008 Oct 14.

PMID:
18922652
2.

The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.

Merrick GS, Butler WM, Wallner KE, Lief JH, Anderson RL, Smeiles BJ, Galbreath RW, Benson ML.

Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1055-62.

PMID:
12419431
3.

A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.

Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.

Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):597-604.

PMID:
11395225
4.

Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.

Kiteley RA, Lee WR, deGuzman AF, Mirzaei M, McCullough DL.

Brachytherapy. 2002;1(2):90-4.

PMID:
15062176
5.

Erectile function after prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):437-47.

PMID:
15890585
6.

A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.

Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1069-74.

PMID:
11072164
7.

Erectile function after permanent prostate brachytherapy.

Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):893-902.

PMID:
11958881
8.

Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy.

Wright JL, Newhouse JH, Laguna JL, Vecchio D, Ennis RD.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):426-35.

PMID:
15145159
9.

Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?

Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):155-63.

PMID:
16111584
10.

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, Webb S, Khoo VS; MRC RT01 Trial Management Group, Dearnaley DP.

Radiother Oncol. 2006 Sep;80(3):355-62. Epub 2006 Sep 1.

PMID:
16949694
11.

Long-term potency preservation following brachytherapy for prostate cancer.

Snyder KM, Stock RG, Buckstein M, Stone NN.

BJU Int. 2012 Jul;110(2):221-5. doi: 10.1111/j.1464-410X.2011.10800.x. Epub 2012 Feb 16.

12.

Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.

Stock RG, Stone NN, Iannuzzi C.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):267-72.

PMID:
8635932
13.

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.

Nobes JP, Khaksar SJ, Hawkins MA, Cunningham MJ, Langley SE, Laing RW.

Radiother Oncol. 2008 Jul;88(1):121-6. doi: 10.1016/j.radonc.2008.04.012. Epub 2008 May 20.

PMID:
18499289
14.

Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.

Taussky D, Haider M, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J.

Brachytherapy. 2004;3(3):125-9.

PMID:
15533803
15.

Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.

Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e765-71. doi: 10.1016/j.ijrobp.2011.11.004. Epub 2012 Jan 31.

16.

Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.

Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1357-63.

PMID:
15590165
17.

Erectile function durability following permanent prostate brachytherapy.

Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):639-48. doi: 10.1016/j.ijrobp.2008.11.058. Epub 2009 Mar 21.

PMID:
19303721
18.

The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.

Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1383-91.

PMID:
15275723
19.

Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.

Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1039-46.

PMID:
15234037
20.

Brachytherapy radiation doses to the neurovascular bundles.

DiBiase SJ, Wallner K, Tralins K, Sutlief S.

Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1301-7.

PMID:
10725644

Supplemental Content

Support Center